These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24894841)

  • 21. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk.
    Zeleznik OA; Eliassen AH; Kraft P; Poole EM; Rosner BA; Jeanfavre S; Deik AA; Bullock K; Hitchcock DS; Avila-Pacheco J; Clish CB; Tworoger SS
    Cancer Res; 2020 Mar; 80(6):1357-1367. PubMed ID: 31969373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.
    Moore SC; Playdon MC; Sampson JN; Hoover RN; Trabert B; Matthews CE; Ziegler RG
    J Natl Cancer Inst; 2018 Jun; 110(6):588-597. PubMed ID: 29325144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
    EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabonomics identifies serum metabolite markers of colorectal cancer.
    Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
    J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk.
    Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
    World J Gastroenterol; 2012 Jun; 18(22):2805-12. PubMed ID: 22719189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
    Inamura K; Song M; Jung S; Nishihara R; Yamauchi M; Lochhead P; Qian ZR; Kim SA; Mima K; Sukawa Y; Masuda A; Imamura Y; Zhang X; Pollak MN; Mantzoros CS; Harris CC; Giovannucci E; Fuchs CS; Cho E; Chan AT; Wu K; Ogino S
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk.
    Shu X; Zheng W; Yu D; Li HL; Lan Q; Yang G; Cai H; Ma X; Rothman N; Gao YT; Jia W; Xiang YB; Shu XO
    Int J Cancer; 2018 Nov; 143(9):2161-2167. PubMed ID: 29717485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer.
    Loftfield E; Falk RT; Sampson JN; Huang WY; Hullings A; Murphy G; Weinstein SJ; Albanes D; Freedman ND; Sinha R
    JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35583137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
    Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hada M; Edin ML; Hartge P; Lih FB; Wentzensen N; Zeldin DC; Trabert B
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):189-197. PubMed ID: 30262599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of 102 Correlations between Serum Metabolites and Habitual Diet in a Metabolomics Study of the Prostate, Lung, Colorectal, and Ovarian Cancer Trial.
    Mazzilli KM; McClain KM; Lipworth L; Playdon MC; Sampson JN; Clish CB; Gerszten RE; Freedman ND; Moore SC
    J Nutr; 2020 Apr; 150(4):694-703. PubMed ID: 31848620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global and targeted serum metabolic profiling of colorectal cancer progression.
    Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
    Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition.
    Rinaldi S; Rohrmann S; Jenab M; Biessy C; Sieri S; Palli D; Tumino R; Mattiello A; Vineis P; Nieters A; Linseisen J; Pischon T; Boeing H; Hallmans G; Palmqvist R; Manjer J; Wirfält E; Crowe FL; Khaw KT; Bingham S; Tjønneland A; Olsen A; Overvad K; Lund E; Skeie G; Clavel-Chapelon F; Boutron-Ruault MC; de Lauzon-Guillain B; Ardanaz E; Jakszyn P; Ramon Quiros J; Chirlaque MD; Sanchez MJ; Dorronsoro M; Trichopoulou A; Lagiou P; Trichopoulos D; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Slimani N; Ferrari P; Byrnes GB; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3108-15. PubMed ID: 18990751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
    Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
    BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.